Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $12 | $35 | $40 |
| Short-Term Investments | $1 | $1 | $11 | $24 |
| Receivables | $2 | $3 | $2 | $2 |
| Inventory | $3 | $3 | $5 | $5 |
| Other Curr. Assets | $1 | $5 | $3 | $2 |
| Total Curr. Assets | $22 | $24 | $56 | $73 |
| Property Plant & Equip (Net) | $6 | $5 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $1 | $2 |
| Total NC Assets | $6 | $7 | $9 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $29 | $31 | $65 | $83 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $2 |
| Short-Term Debt | $17 | $2 | $58 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $2 | $1 | $0 |
| Other Curr. Liab. | $8 | $3 | $3 | $3 |
| Total Curr. Liab. | $31 | $12 | $67 | $7 |
| LT Debt | $49 | $37 | $19 | $110 |
| Deferred Rev, NC | $2 | $1 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $1 | $2 | $1 |
| Total NC Liab. | $53 | $39 | $21 | $111 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $2 | $4 | $3 |
| Total Liabilities | $85 | $51 | $87 | $118 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$719 | -$669 | -$607 | -$571 |
| AOCI | -$0 | -$1 | -$0 | -$0 |
| Other Equity | $663 | $650 | $585 | $536 |
| Total Equity | -$56 | -$20 | -$22 | -$35 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $29 | $31 | $65 | $83 |
| Net Debt | $51 | $27 | $43 | $72 |